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1. SUMMARY 
Lipoteichoic acids (LTAs) of varying chemical 
composition from five streptococcal species and 
one lactobacillus species initiated gelation of 
Limu lus  amebocyte lysate. Preincubation with an- 
tisera specific for the poly(glycerol phosphate) 
(PGP) chain or, when appropriate, with antisera, 
specific for a carbohydrate substituent inhibited 
gelation initiated by lipoteichoic acid, but did not 
inhibit  l ipopolysaccharide-ini t ia ted gelation. 
Higher specific activities were found for those 
LTAs with higher D-alanine or carbohydrate sub- 
stitution or with a shortened PGP chain, which 
suggested that those structural features which de- 
creased the relative hydrophilicity or charge to 
mass ratio appeared to increase the specific activ- 
ity. 
2. INTRODUCTION 
The Limulus  amebocyte lysate (LAL) assay is 
widely used as a substitute for the rabbit pyrogen 
test for detecting contamination of pharmaceuti- 
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cals and other therapeutic products with pyrogenic 
endotoxins; i.e., lipopolysaccharides (LPSs) from 
gram-negative bacteria [1,2]. In clinical medicine, 
LAL assay results have been shown to correlate 
well with the presence of gram-negative bacteria in 
urine and cerebrospinal fluids and cervical 
exudates (summarized in [3]). Positive LAL reac- 
tions with blood samples have been correlated 
with gram-negative infections, although there are 
probleths with inhibitors in blood [2]. There also is 
a report of some patients with gram-positive infec- 
tions yielding positive LAL assay results [4], a 
finding not observed in other studies [1,3]. 
Although the reaction of LAL with LPS has 
been considered to be highly specific, apparently 
by virtue of the high sensitivity for LPS, other 
compounds have also been shown to initiate ge- 
lation of LAL. Positive reactions have been re- 
ported for proteins and polynucleotides [5], 
peptidoglycans [6], a water-soluble carboxymethy- 
lated dextran [7] and lipoteichoic acid (ETA) [8]. 
The mechanism of gelation is different with the 
dextran [7]; the mechanism of activation has not 
been determined for any of the others. In most 
cases the relative amounts required for gelation are 
3-6  orders of magnitude greater than that of 
highly reactive LPS standards. However, not all 
LPSs are as active as these standards and a wide 
range of relative activity may be found [9]. 
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LTAs share the common feature of a 
poly(glycerol phosphate) (PGP) chain, usually 
20-30 units in length, that is covalently attached 
to a lipid moiety. The lipid moiety is usually 
identical to a membrane glycolipid or phosphati- 
dyl glycolipid [10]. LTAs differ in the extent and 
type of substitution on the PGP chain. Substitu- 
tion at the second carbon of the glycerols may be 
in the form of D-alanine in ester linkage or sugars 
attached by glycosidic bonds, or both [10]. Highly 
sugar-substituted LTAs may bear the alanine on a 
hydroxyl group of the sugar residue [10]. Presented 
in this report is further documentation for the 
gelation of LAL in the presence of LTA, and 
results that demonstrated that differences in LTA 
structure influenced the minimum amount of LTA 
required to initiate LAL gelation. It appeared that 
those structural features which decrease the rela- 
tive hydrophilicity, or charge to mass ratio of LTA 
increase the specific activity. 
3. MATERIALS AND METHODS 
Limulus amebocyte lysate (Limusate, lot nos. 
61B1 and 81B1) and LPS from Escherichia coil 
055 : B5 were obtained from Calbiochem (San Di- 
ego, CA). These lots had listed potencies of 0.022 
and 0.018 ng /ml ,  respectively, with FDA refer- 
ence standard EC2 and tested potencies of 0.2 and 
0.1 n g / m l  with LPS 055 : B5. The manufacturer's 
directions for reconstitution, storage and usage 
were rigorously followed. Sterile pyrogen-free water 
was used for reconstitution of lyophilized LAL, 
LPS, LTAs and for all dilutions thereof. Recon- 
stituted LAL was kept on ice and used within 4 h 
of reconstitution or frozen at - 2 0 ° C  for up to 1 
week. All glassware was rendered pyrogen-free by 
baking at 210°C for 4 h in a dry air oven. The 
assay was carried out in 10 × 75 mm glass tubes 
with equal volumes of sample and LAL (0.1 ml). A 
positive reaction was recorded only for a firm clot 
which remained in the tube upon inversion after 
exactly 60 rain at 37°C. Endpoints of clotting were 
determined by assaying 10-fold dilutions and then 
assaying concentrations between the lowest posi- 
tive dilution and the highest negative dilution. 
Every group of tests included a negative control 
(pyrogen-free water) and a positive control of LPS 
at the minimum concentration required for ge- 
lation. All endpoints reported here were de- 
termined with the 81B1 lot; duplicate experiments 
with the 61B1 lot gave similar results but at ap- 
proximately 2-fold higher levels. 
The LTAs used in these experiments were avail- 
able from a previous study [11] except for the LTA 
from Lactobacillus casei NCTC 6991 which was 
kindly provided as a reference standard by Dr. 
A.J. Wicken, University of New South Wales. 
Precautions were taken to prevent LPS contamina- 
tion during growth of the bacteria and during 
preparation of each LTA; i.e., monitoring cultures 
for contamination with gram-negative bacteria, 
baking glassware, and testing of glass distilled 
water, buffers and column effluents for LAL activ- 
ity (all negative). 
Fatty acid esters were hydrolyzed in 0.2 N 
KOH in methanol, J5 min at 37°C [13]. The PGP 
chain of dealanylated group A streptococcal LTA 
was enzymatically shortened using a phos- 
phodiesterase-phosphomonoesterase mixture pre- 
pared as described by Fischer et al. [14]. Progress 
of the reaction was measured by the release of 
glycerol (Boehringer-Mannheim, Indianapolis, IN). 
LTA was separated from free glycerol and enzyme 
by chromatography on AcA22 [15]. The final chain 
length was determined by the ratio of phosphorus 
to glucose [16]. 
4. RESULTS AND DISCUSSION 
The sources and phosphorus : glucose : alanine 
ratios of the LTAs used in this study are given in 
Table 1. Glucose content provides a rough esti- 
mate of the degree of carbohydrate substitution on 
these LTAs [11]. All of the glucose of LTAs I and 
II from the group A streptococci is solely within 
the glycolipid moiety, but the additional glucose 
content of LTAs I l l -VI I  is found in glycosidic 
linkage along the PGP chain in the form of 
kojibiose, kojitriose, or possibly both [18,19]. 
LTAs with carbohydrate and alanine at ap- 
proximately the same percentage substitution were 
nearly equivalent in activity (Table 1, cf. LTAs I 
and II with III). The presence of alanine on the 
Table  1 
Lipote ichoic  acid compos i t ions  and  ge la t ion  endpo in t s  
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LTA a Source P : Glc  : Ala  b Ge la t ion  endpo in t  c Phosphorus  equiva lents  
(t~g) (nmol)  
I G r o u p  A Streptococcus  ($43) 1 : 0.09 : 0.43 0.5 1.9 
II  G r o u p  A St reptococcus  (2GL318)  1 : 0.07 : 0.29 0.5 1.9 
I I I  G r o u p  D s t reptococcus  (S. faecalis JH2-2) 1 : 0.38 : 0.34 0.5 1.5 
IV G r o u p  D Streptococcus  (S. faecium ATCC9790)  1 : 1.04 : 0.33 0.25 0.525 
V G r o u p  D Streptococcus  (S. faecium ATCC9790)  1 : 1 .05:0.03 0.25 0.50 
VI G r o u p  D St reptococcus  (S. faecium ATCC9790)  1 : 1.46 : 0.03 0.25 0.45 
VII  G r o u p  D Streptococcus  (S. faecium NCIB8191)  1 : 2 .47:0 .13 0.025 0.012 
VII I  Lactobacillusfermenturn NCTC6991 N D  d 0.5 N D  
a Two prepara t ions  each of LTAs  I, III ,  IV, V, VII  were tested. Resul ts  were equiva len t  for each pair.  
b Phosphorus  : glucose : a lan ine  ratios. 
c L T A / 0 . 1  ml pr ior  to add i t ion  of 0.1 ml  LAL.  
d Not  determined.  
carbohydrate substituent did not appear to in- 
fluence the relative activity (cf. LTAs IV and V). 
The highest activity (LTA VII) appeared to be 
associated with a high degree of substitution with 
the longest glycoside chain (a trisaccharide). The 
equivalent nmol phosphorus for each LTA gela- 
tion endpoint is given in Table 1 for purposes of 
comparison since the ratio of mol LTA/unit  dry 
weight varies with chain length and substitution. 
Higher concentrations of LTA were required for 
LAL gelation after removal of alanine from LTAs 
I and II (Table 2). The LTAs and dealanylated 
LTAs were compared here on the basis of phos- 
phorus content since chain lengths of native and 
derivative polymers in this case are the same, and 
thus equimolar amounts of phosphorus reflect 
Table  2 
Effect  of removal  of ester if ied D-alanine f rom LTA on gela t ion 
of Limulus amebocy te  lysate  
L T A  Ala  : P LTA phosphorus  in react ion mix ture  
(nmol)  
19 9.5 3.8 1.9 
I 0.43 + b 4- + + 
IA a 0.02 + + - - 
I I  0.29 + + + + 
I I A  a 0.01 + + - - 
a Der ived  f rom LTA wi th  co r re spond ing  numera l  by dialysis  
aga ins t  0.1 M T r i s - H C l  buffer  (pH 8.0) for 24 h at  37°C and  
then agains t  d is t i l led  water  (3 changes)  for 24 h at  4 °C  [12]. 
b + ,  gelat ion.  
equimolar amounts of the LTAs. 
To provide further evidence for LTA-initiation 
of gelation, and the absence of LPS in LTA pre- 
parations, inhibition of gelation by pretreating a 
moderately substituted LTA and the highly sub- 
stituted LTA VII with antisera was attempted. At 
concentrations of LTA close to the minimum 
Tab le  3 
Inh ib i t ion  of Limulus amebocy te  lysate  ge la t ion  with ant i l ipo-  
teichoic acid ant i sera  
LTA Ant i se rum added  ~ Ge la t ion  
No.  A m o u n t  A n t i - P G p b  A n t i - G r p D C  
(/xg/O.1 ml) (ktl) (~ l )  
I I I  
VII  





0 0 + 
2 0 - 
10 0 + 
10 10 - 
0 0 + 
5 0 - 
0 5 - 
5 0 + 
0 5 + 
10 10 - 
1 0  0 - 
0 10 - 
a Ant i se ra  were added  to LTA and  the mix ture  incuba ted  for 
15 min  at  37°C pr ior  to addi t ion  of L A L  (0.1 ml). 
b An t i se rum prepared  agains t  LTA from L. casei NCTC6375  
and  demons t ra t ed  to be  PGP-specif ic  by  Dr. K.W. Knox.  
Streptococcal  g roup  D an t i se rum (specific for g roup  D LTA 
since LTA is the g roup  D ant igen  [17]). 
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amount required for gelation, inhibition of gela- 
tion was possible with antisera directed against 
either the PGP backbone alone or antiserum di- 
rected predominantly against the substituents of 
the group D LTA (Table 3). At higher concentra- 
tions of LTA, a combination of both antisera was 
effective. Neither antisera inhibited LPS-initiated 
LAL gelation at concentrations of 0.1-10 n g / m l  
LPS. 
Removal of fatty acids by mild base hydrolysis 
increased the minimum amount of LTA III re- 
quired for LAL gelation from 0.5 t~g to > 20 ~g. 
No gelation was observed at 20/ag, but a positive 
reaction was seen at 200 ~g, which was the next 
highest concentration tested. Since the base-treated 
LTA was also rechromatographed, it is not likely 
that there was any residual, partially deacylated 
LTA remaining. Thus it would appear that intact 
fatty acids are not required for LAL activation, 
although they certainly augment the activity. This 
may be related to differences in physical structure; 
i.e., formation of vesicular aggregates of LTA but 
not deacylated LTA. 
LTA II was dealanylated (LTA IIA), then 
shortened enzymatically, and rechromatographed 
yielding a preparation with a reduced average 
chain length of 14.5 (LTA IIB) as compared to the 
original average chain length of 28. The minimum 
amount required for LAL gelation decreased from 
9.5 nmol LTA phosphorus (2.15 /~g) of LTA IIA 
(Table 2) to 0.49 nmol LTA phosphorus (0.25/lg) 
of the shortened LTA IIB. Since there are ap- 
proximately 2,1-times as many molecules of LTA 
IIB per unit mass as there are of LTA IIA, reduc- 
tion in chain length resulted in a net 4-fold in- 
crease in specific activity on a molar basis. Al- 
though the effect of shortening the PGP chain 
further and the minimum chain lengths for LAL 
activation were not determined, neutralized acid 
hydrolysates were negative at 50 t~g of material. 
In summary, specific antibody inhibition of 
LTA-initiated gelation but not LPS-initiated gela- 
tion provided definitive evidence for LTA-initiated 
gelation of LAL. The apparently higher specific 
activities found with higher substituted LTAs or 
LTA with decreased chain length suggested that 
those structural features which decreased the rela- 
tive hydrophilicity or charge to mass ratio ap- 
peared to increase the specific activity of the LTA 
molecule for initiation of the LAL clotting mecha- 
nism. 
A CK N O W LED G EMEN TS  
This research was supported by United States 
Public Health Service Grant DE02731. I thank Dr. 
K.W. Knox, Institute of Dental Research, Sydney, 
Australia and Dr. L. Pine, Center for Disease 
Control, Atlanta, Georgia, USA for generously 
providing antisera with specificity for PGP and 
the streptococcal group D antigen, respectively. 
REFERENCES 
[1] Cooper, J.F. (1979) in Biomedical Applications of the 
Horseshoe Crab (Limulidae) (Cohen, E., Ed.) pp. 345-352, 
Liss, New York. 
[2] Levin, J. (1979) in Biomedical Applications of the 
Horseshoe Crab (Limulidae) (Cohen, E., Ed.) pp. 235-244. 
Liss, New York. 
[3] Fink, P.C., Lehr, L., Urbaschek, R.M. and Kozak, J. 
(1981) Klin. Wochenschr. 59, 213-218. 
[4] Stumacher, R.J., Kovnat, M.J. and McCabe, W.R. (1973) 
N. Engl. J. Med. 288, 1261-1269. 
[5] Elin, R.J. and Wolff, S.M. (1973) J. Infect. Dis. 128, 
349-352. 
[6] Wildfeuer, A., Heymer, B., Spilker, D., Schleifer, K.-H., 
Vanek, E. and Haferkamp, O. (1975) Z. Immun. Forsch. 
Bd. 149, 258-264. 
[7] Kakinuma, A., Asano, T., Torii, H. and Sugino, Y. (1981) 
Biochem. Biophys. Res. Comun. 101,434-439. 
[8] Fine, D.H., Kessler, R.E., Tabak, L.A. and Shockman, 
G.D. (1977) J. Dent. Res. 56, 1500. 
[9] Elin, R.J., Sandberg, A.L. and Rosenstreich, D.L. (1976) J. 
Immunol. 117, 1238-1242. 
[10] Wicken, A.J. and Knox, K.W. (1980) Biochim. Biophys. 
Acta 604, 1-26. 
[111 Kessler, R.E. and Thivierge, B.H. (1983) Infect. Immun. 
41, 549-555. 
[121 Fischer, W., Koch, H.U., Rosel, P. and Fiedler, F. (1980) 
J. Biol. Chem. 255, 4557-4562. 
[131 Wicken, A.J., Gibbens, J.W. and Knox, K.W. (1973) J. 
Bacteriol. 113, 365-372. 
[14] Fischer, W., Koch, H.U., Rosel, P., Fiedler, F. and 
Schmuck, L. (1980) J. Biol. Chem. 255, 4550-4556. 
[15] Jacques, N.A., Hardy, L., Campbell, L.K., Knox, K.W., 
Evan, J.D. and Wicken, A.J. (1979) Infect. lmmun. 26, 
1079-1087. 
[16] Kessler, R.E., van de Rijn, I. and McCarty, M. (1979) J. 
Exp. Med. 150, 1498-1509. 
[17] Wicken, A.J., Elliott, S.D. and Baddiley, J. (1963) J. Gen. 
Microbiol. 31,231-239. 
[18] Wicken, A.J. and Baddiley, J. (1963) Biochem. J. 87, 
54-62. 
[19] Fischer, W., Rosel, P. and Koch, H.U. (1981) J. Bacteriol. 
146, 467-475. 
